| Literature DB >> 35770099 |
Liya Liu1,2,3, Fei Cai1,2,3, Yitong Lu2, Yuting Xie2, Hao Li2, Chunlin Long1,2,3.
Abstract
Background: In southwest China, especially in Nujiang, lacquer oil from the drupes of Toxicodendron vernicifluum (Stokes) F. A. Barkley, including black lacquer oil (BLO) and white lacquer oil (WLO), is one of the most important edible oils for the local people. Through the field investigation, the locals believe that lacquer oil has benefits for parturient women and for the treatment of "Yuezi" disease. However, studies on bioactivities and the chemical compositions of lacquer oil are limited. Purpose: This study was designed to reveal the mystery of lacquer oil for the treatment of "Yuezi" disease by testing its anti-inflammatory and anti-postpartum depressant activities and related bioactive compounds.Entities:
Keywords: anti-infammation; anti-postpartum depression; ethnopharmacology; lacquer oil; lipidomics; metabolomics; “yuezi” disease
Year: 2022 PMID: 35770099 PMCID: PMC9234167 DOI: 10.3389/fphar.2022.914951
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.988
FIGURE 1Anti-inflammatory effects of BLO and WLO in LPS-induced RAW264.7 cells (X ± SEM, n = 3). (A): Cytotoxic effects of BLO and WLO on RAW264.7 cells. The cells were incubated with different concentrations of BLO and WLO for 24 h, and then the cell viability was detected by CCK-8 assay. (B–D): Effects of BLO and WLO on NO (B), IL-6 (C) and TNF-α (D) release in LPS-challenged RAW264.7 cells. The RAW264.7 cells were treated with BLO or WLO for 1 h and then added LPS for an additional 18 h ***p < 0.001 vs. Control group. # p < 0.05, ## p < 0.01, ### p < 0.001 vs. LPS group.
FIGURE 2The effects of BLO and WLO on the depression-related behaviors in PPD model mice (X ± SEM, n = 8). (A): Time course of the experimental procedure. (B,C): The total distances explored and the time spent in the center region in OFT. (D,E): The immobility time in FST and TST. *p < 0.05 vs. Control group; p < 0.05, ## p < 0.01 vs. Model group.
FIGURE 3Lipidomic studies by UPLC-MS/MS on the lipid constituents of BLO and WLO. (A): The number of lipids detected and annotated in BLO and WLO. (B,C): The composition of lipids detected and annotated in BLO and WLO. (D,E): Multivariate data analysis of UPLC-MS/MS data of BLO and WLO. Score scatter plot of the PCA (D) and OPLS-DA (E) derived from the UPLC-MS/MS data of BLO and WLO lipidomic profiles. (F): Volcano plot showing the different lipids between BLO and WLO. (G): Differences in the significantly different lipid subclasses between BLO and WLO. **p < 0.01, ***p < 0.001.
FIGURE 4Untargeted metabolomics studies by UPLC-MS/MS on the secondary metabolites composition of BLO and WLO. (A,B): Multivariate data analysis of UHPLC-MS data of BLO and WLO. PCA (A) and OPLS-DA (B) score plots derived from the UPLC-MS/MS data of BLO and WLO metabolite profiles. Volcano plot (C) and Heatmap (D) used to visualize the different metabolites in BLO compared to WLO.